USA
On March 7, 2023, the firm secured a $131.4 million default judgment on behalf of a leading biopharmaceutical company, against Florida-based clinics in connection with a fraudulent HIV medication scam. The suit, initially filed in November 2020 in Florida federal court, alleges that two Florida-based healthcare networks engaged in schemes to defraud our client’s charitable medication assistance program for pre-exposure prophylaxis, or PrEP, a critical HIV infection prevention medication
USA
Patterson Belknap Webb & Tyler LLP today announced the launch of Securities Litigation Insider, a blog covering a wide range of topics relevant to securities litigation, including notable developments such as U.S. Securities and Exchange Commission (SEC) enforcement, SEC rulemaking, securities class actions, and developments in blockchain and crypto-asset regulation, among other areas
USA
Patterson Belknap Webb & Tyler LLP is pleased to announce that, effective January 1, 2022, Douglas L. Tang, Amy N. Vegari, and Timothy A. Waters will become partners of the Firm, and Susan M. Vignola, Lisa Wang, and Justin Zaremby will become counsel. Douglas L
USA
Potter becomes sixth former federal prosecutor to join Firm’s White Collar Defense & Investigations Team Patterson Belknap Webb & Tyler LLP is pleased to announce that Lauren Schorr Potter, a former Assistant United States Attorney for the Southern District of New York, has joined the Firm as a partner in the Litigation department. Ms. Potter will focus her practice on white collar defense and investigations and complex civil litigation. Prior to joining Patterson, Ms
USA
In February, the Firm secured a settlement for our client, a multinational biotech company, in the U.S. District Court for the Northern District of Alabama. The suit accused the defendant, a group of pharmacies in Alabama, Mississippi, and Arkansas, of selling consumers thousands of boxes of our client’s blood glucose test strips that were not intended for retail sale
USA
In August 2020, the Firm continued its longstanding pro bono representation of the National Citizenship and Immigration Council 119, which represents over 14,000 employees of the United States Citizenship and Immigration Services (“Council 119”). Council 119 has been a steadfast and vocal critic of the Administration’s policies imposing limitations on refugees seeking protection in the United States
USA
Patterson Belknap scored an appellate win in a novel class action concerning the labeling of Hershey’s chocolates. The plaintiff alleged that Hershey’s product labeling violated Massachusetts consumer protection laws because it did not disclose that some cocoa may be indirectly sourced from regions in West Africa where child labor is used
USA
On March 24, 2020, Patterson Belknap Webb & Tyler LLP secured a case-ending victory for our client, a medical device manufacturer, in the U.S. District Court for the Eastern District of New York. The defendant was sanctioned for perpetrating fraud on the court by withholding information and relevant documents in bad faith during discovery, as set forth in Judge Lois Bloom’s Report and Recommendation in May of last year
USA
On July 27, 2018, Patterson Belknap scored a win for our client, a Fortune 100 healthcare company, when the court granted a motion to dismiss for lack of personal jurisdiction in a products liability suit related to talcum powder. The New York Supreme Court in Manhattan relied on the U.S. Supreme Court’s opinion in Bristol-Myers Squibb Co v. Superior Court of California, San Francisco, 136 S. Ct
USA
On March 7, 2018, the Hon. LaShann Dearcy Hall, U.S. District Judge for the Eastern District of New York, adopted a January 16, 2018 Report and Recommendation of Magistrate Judge Steven M. Gold, granting “a permanent injunction prohibiting all defendants from infringing, counterfeiting, or otherwise violating” our client’s federally registered trademark on a blood glucose test strip, which is used by diabetics to monitor their blood glucose levels
USA
On December 22, 2017, Patterson Belknap secured a significant victory for Maine Secretary of State Matt Dunlap when a federal judge ruled that Secretary Dunlap cannot be excluded from participating in the work of the Presidential Advisory Commission on Election Integrity (PACEI) on which he serves as a member. Together with American Oversight, Patterson Belknap filed the lawsuit in November
USA
Patterson Belknap won a permanent injunction in the Eastern District of New York on behalf of a medical device manufacturer. The injunction bans multiple distributors from buying, selling or importing counterfeit versions of a blood glucose test strip our client produces. The strip, which is used by diabetics to monitor their blood glucose levels, has been the victim of counterfeiting multiple times, forcing our client to take action on several occasions
New York, USA
“Patterson Belknap Webb & Tyler LLP recently authored the mini-treatise, “New York’s Cybersecurity Regulation for Financial Institutions, A New Age of Cybersecurity Regulation: Raising the Bar and Demanding Leadership Accountability”. The mini-treatise, published by and available on Bloomberg Law provides a general overview of the sweeping new cybersecurity regulations issued by the New York State Department of Financial Services, the state’s top banking and insurance regulator
New York, USA
Patterson Belknap is pleased to announce that Daniel A. Lowenthal has been named as Chair of the Firm’s Business Reorganization and Creditors' Rights Practice. Mr. Lowenthal has earned recognition as a skilled advocate in the bankruptcy, creditors' rights, and corporate restructuring arena. He regularly represents U.S. and non-U.S
